Napredna pretraga

Pregled bibliografske jedinice broj: 196428

Murine myeloid leukemia: in vivo suppression by sericystatin A, a proteinase inhibitor from leukocytes


Pavelić, Krešimir; Sirotković, Maja; Kopitar, Marija; Pavelić, Jasminka; Vuk-Pavlović, Stanimir
Murine myeloid leukemia: in vivo suppression by sericystatin A, a proteinase inhibitor from leukocytes // European journal of cancer & clinical oncology, 19 (1983), 1; 123-126 doi:10.1016/0277-5379(83)90406-6 (međunarodna recenzija, članak, znanstveni)


Naslov
Murine myeloid leukemia: in vivo suppression by sericystatin A, a proteinase inhibitor from leukocytes

Autori
Pavelić, Krešimir ; Sirotković, Maja ; Kopitar, Marija ; Pavelić, Jasminka ; Vuk-Pavlović, Stanimir

Izvornik
European journal of cancer & clinical oncology (0277-5379) 19 (1983), 1; 123-126

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Murine myeloid leukemia ; sericistatin A

Sažetak
Parenteral administration of sericystatin A, an intracellular leukocyte inhibitor of the proinsulin-splitting enzyme cathepsin B, prolongs the mean survival time of mice with insulin-dependent myeloid leukemia. Sericystatin A reduces the supranormal blood levels of substances detectable by insulin-specific radioimmunoassay in these animals ; this effect is abolished by concomitant insulin administration. It is concluded that sericystatin A reduces tumor proliferation indirectly, i.e. by reducing circulating insulin levels.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Ustanove
Imunološki zavod d.d.,
Institut "Ruđer Bošković", Zagreb

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Uključenost u ostale bibliografske baze podataka:


  • Excerpta Medica
  • Index Medicus


Citati